Strategic Stakes: Stellar Wealth’s Entry into Sakar Healthcare and Zerodha’s Bold Move in Nazara Tech
How two prominent investors reposition portfolios as healthcare and digital entertainment seize market attention
Stellar Wealth Partners India Fund has acquired nearly a one percent stake in Sakar Healthcare, reflecting confidence in the pharmaceutical services sector’s growth prospects. Meanwhile, leading retail broker Zerodha has invested Rs 93 crore in Nazara Tech shares, underscoring the rising appeal of gamified digital content in India’s booming media landscape.
Market Overview
The Indian equity market has witnessed targeted portfolio adjustments by both foreign and domestic investors in recent trading sessions. Healthcare and digital entertainment continue to draw significant interest as investors seek diversification amid modest GDP growth and periodic volatility. Sakar Healthcare, engaged in contract development manufacturing organizations for pharmaceuticals and nutraceuticals, has built a solid niche with a growing order book. Concurrently, Nazara Tech, a leading gaming and sports media platform, has captured investor imagination with its compelling monetization strategies and scalable user base.
Stellar Wealth Partners’ Bet on Sakar Healthcare
Stellar Wealth Partners India Fund, an offshore private equity vehicle focusing on Indian mid market companies, recently filed a shareholding update indicating a purchase of 4.33 lakh equity shares in Sakar Healthcare, raising its holding to 0.87 percent. The transaction value, estimated close to Rs 18 crore, marks one of the fund’s largest equity moves this quarter. According to fund sources, the decision was driven by the company’s robust revenue visibility and expansion into regulated markets abroad. Sakar Healthcare’s order pipeline includes several leading global pharmaceutical companies, offering margin stability and long term revenue growth.
Historical data reveal Sakar Healthcare’s revenue CAGR of 24 percent over the last three years, driven by increased demand for contract pharmaceutical services and a strategic focus on specialized segments such as oncology APIs. Analysts expect the firm to maintain EBITDA margins in the midteens, supported by operational leverage and improving product mix. Stellar Wealth’s acquisition also signals confidence in management’s ability to execute aggressive capacity expansions at its Gujarat and Maharashtra facilities.
Zerodha Broking’s Investment in Nazara Tech
In an unconventional move for a retail broker, Zerodha Broking has purchased equity shares in Nazara Tech worth Rs 93 crore. The stake acquisition was executed through block deals on the bourses, with Zerodha aiming to hold approximately 1.2 percent of the company’s equity. Nazara Tech, founded in 2000, has evolved into a diversified gaming ecosystem that includes skill gaming tournaments, subscription based mobile content, and e sports tournaments. The firm’s marquee acquisitions, including sports media platform Sportskeeda, have bolstered user engagement and revenue diversification.
Nazara Tech reported a 52 percent year on year increase in consolidated revenue for the fiscal year ended March 31, primarily led by subscription growth and monetization of live sports gaming. Gross margins have remained above 60 percent, benefiting from digital delivery models and recurring revenue streams. The company’s international expansion into Africa and Latin America adds further growth avenues, as mobile internet penetration continues to accelerate in emerging markets.
Sectoral Performance and Broader Implications
Healthcare services stocks have outperformed the broader Nifty by nearly 8 percent over the past twelve months, driven by steady domestic demand and rising export orders. Contract manufacturing remains a structural growth theme, as global pharmaceutical companies diversify supply chains away from concentrated geographies. Meanwhile, the digital entertainment sector has delivered returns north of 20 percent in the same period, underpinned by rising smartphone adoption, affordable data plans and rising consumer spending on online gaming and media.
Institutional flows into these two sectors signal a rotation from cyclical to structural growth stories. With interest rates in watchful mode and fiscal stimulus tapering, investors are tilting portfolios towards companies with strong cash flows and established market positions.
- 0.87% stake acquired by Stellar Wealth in Sakar Healthcare, indicating faith in mid market pharma growth
- Rs 93 crore investment by Zerodha Broking in Nazara Tech shares via block deal
- 24% CAGR achieved by Sakar Healthcare over the last three years, driven by contract manufacturing
- 52% revenue growth at Nazara Tech for fiscal year ended March, led by subscription and live gaming
- 60%+ gross margins maintained by Nazara Tech due to digital delivery and recurring revenue
Investor Note: Both transactions highlight a strategic pivot towards sectors offering secular growth amid market uncertainties. Stakeholders in Sakar Healthcare and Nazara Tech should monitor capacity expansions, international order book developments and evolving monetization models to gauge long term value creation potential.